Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | Atara Biotherapeutics, Inc. | Fust Matthew K
(Director) |
A | Common Stock | A | 150000 | $0.00 - $0.00 | $0 |
| 2024-03-31 | Atara Biotherapeutics, Inc. | HEIDEN WILLIAM K
(Director) |
A | Common Stock | A | 150000 | $0.00 - $0.00 | $0 |
| 2024-03-31 | Atara Biotherapeutics, Inc. | Roncarolo Maria G...
(Director) |
A | Common Stock | A | 150000 | $0.00 - $0.00 | $0 |
| 2024-03-31 | Atara Biotherapeutics, Inc. | Gallagher Carol G...
(Director) |
A | Common Stock | A | 150000 | $0.00 - $0.00 | $0 |
| 2024-03-31 | Atara Biotherapeutics, Inc. | MALLIK AMEET
(Director) |
A | Common Stock | A | 150000 | $0.00 - $0.00 | $0 |
| 2024-03-04 | Atara Biotherapeutics, Inc. | Touchon Pascal
(President and CEO) |
S | Common Stock | D | 24844 | $0.72 - $0.72 | $17,887 |
| 2024-03-04 | Atara Biotherapeutics, Inc. | Nguyen AnhCo
(EVP, Chief Sci. & Tech Officer) |
S | Common Stock | D | 10746 | $0.72 - $0.72 | $7,737 |
| 2023-11-16 | Atara Biotherapeutics, Inc. | Touchon Pascal
(President and CEO) |
S | Common Stock | D | 20409 | $0.39 - $0.39 | $7,939 |
| 2023-11-16 | Atara Biotherapeutics, Inc. | Nguyen AnhCo
(EVP, Chief Sci. & Tech Officer) |
S | Common Stock | D | 8856 | $0.39 - $0.39 | $3,444 |
| 2023-11-16 | Atara Biotherapeutics, Inc. | Murugan Amar
(EVP, Chief Legal Officer) |
S | Common Stock | D | 8307 | $0.39 - $0.39 | $3,231 |
| 2023-11-16 | Atara Biotherapeutics, Inc. | Joshi Manher
(EVP, Chief Medical Officer) |
S | Common Stock | D | 12287 | $0.39 - $0.39 | $4,779 |
| 2023-11-16 | Atara Biotherapeutics, Inc. | Hyllengren Eric J
(SVP, CFO) |
S | Common Stock | D | 11958 | $0.39 - $0.39 | $4,651 |
| 2023-11-16 | Atara Biotherapeutics, Inc. | Henrich Jill
(EVP, Global Head RA & Quality) |
S | Common Stock | D | 3267 | $0.39 - $0.39 | $1,270 |
| 2023-11-13 | Atara Biotherapeutics, Inc. | Gallagher Carol G...
(Director) |
P | Common Stock | A | 270000 | $0.22 - $0.31 | $68,213 |
| 2023-11-10 | Atara Biotherapeutics, Inc. | HEIDEN WILLIAM K
(Director) |
P | Common Stock | A | 100000 | $0.25 - $0.25 | $25,330 |
| 2023-11-10 | Atara Biotherapeutics, Inc. | DOBMEIER ERIC
(Director) |
P | Common Stock | A | 446825 | $0.23 - $0.23 | $101,339 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |